Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

The report "Hospital Filtration Market by Type (Point of Use Filters, Inline Filters, Standalone Filtration Units, Disposable ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

As the Senior Vice President and President of Clinical Research at Thermo ... Patrick led the Central Laboratory Services ...

Merck Research Laboratories. "This positive opinion is yet another testament to the clinical profile of CAPVAXIVE and brings us a step closer to helping protect adults in the EU against ...

Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...

“Invasive pneumococcal disease and pneumococcal pneumonia remain critical public health challenges worldwide,” said Dr. Paula Annunziato, senior vice president, infectious diseases and vaccines, ...

Merck Research Laboratories. “We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the ...

OpenAI said Thursday that the U.S. National Laboratories will be using its latest artificial intelligence models for scientific research and nuclear weapons security. OpenAI CEO Sam Altman ...